Mellen Center for Multiple Sclerosis focuses on addressing physical, emotional, cognitive and rehabilitation needs of the MS patient and their family members through a team approach.
Mellen Center physicians are national leaders in basic and clinical research related to MS pathogenesis and medical management and have made major contributions in the development of drugs to control MS disease activity and progression. They provide consultative services for neurologists and patients world-wide and ongoing care for approximately 8,000 MS patients annually, including approximately 1,600 new patient/consult visits.
Program highlights for the Mellen Center include:
- clinical research
- Integration of neurorehabilitation with spasticity management through the use of baclofen pumps and Botox injections
- Standard and investigational imaging provided through standard and high field strength MRI equipment staffed by an expert team
- Latest pharmaceutical therapies delivered in the setting of a new, 15-chair infusion center
The Mellen Center provides significant clinical research opportunities available for Mellen Center patients, ranging from genetic studies through trials of new treatments. Funded research for basic and clinical science totaled $7,910,812.27 at the Mellen Center in 2013, representing a large research program in experimental therapeutics, neuroimaging, neurorehabilitation, neurobiology and immunology.